Matches in Nanopublications for { ?s ?p "[One area of gene therapy that has generated much debate and controversy is the use of vascular endothelial growth factor (VEGF) for therapeutic angiogenesis for palliative intent, and for the prevention of restenosis following percutaneous revascularization in coronary and peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP227803.RAkOc-D42le3LWVxNF2MykhZ4JEFFH8JoF-rRRS4clTzk130_assertion description "[One area of gene therapy that has generated much debate and controversy is the use of vascular endothelial growth factor (VEGF) for therapeutic angiogenesis for palliative intent, and for the prevention of restenosis following percutaneous revascularization in coronary and peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227803.RAkOc-D42le3LWVxNF2MykhZ4JEFFH8JoF-rRRS4clTzk130_provenance.
- NP864323.RAWn_XsBj3pynPdyAPFj-3UwPxAfpt54Ni5eqCW3H-Lw0130_assertion description "[One area of gene therapy that has generated much debate and controversy is the use of vascular endothelial growth factor (VEGF) for therapeutic angiogenesis for palliative intent, and for the prevention of restenosis following percutaneous revascularization in coronary and peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864323.RAWn_XsBj3pynPdyAPFj-3UwPxAfpt54Ni5eqCW3H-Lw0130_provenance.
- NP771233.RAd6QlaN7TdpflUSmd44zxU_3okGxDzmwhHXBZw6z1FKg130_assertion description "[One area of gene therapy that has generated much debate and controversy is the use of vascular endothelial growth factor (VEGF) for therapeutic angiogenesis for palliative intent, and for the prevention of restenosis following percutaneous revascularization in coronary and peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771233.RAd6QlaN7TdpflUSmd44zxU_3okGxDzmwhHXBZw6z1FKg130_provenance.
- NP772733.RA7oazTpKzQaeKvk6b2T1VMet-mB3U8ydwq_XRkRltdQY130_assertion description "[One area of gene therapy that has generated much debate and controversy is the use of vascular endothelial growth factor (VEGF) for therapeutic angiogenesis for palliative intent, and for the prevention of restenosis following percutaneous revascularization in coronary and peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772733.RA7oazTpKzQaeKvk6b2T1VMet-mB3U8ydwq_XRkRltdQY130_provenance.
- NP448039.RA0caSYltOPQpHlLdzs9PrJH7AteYpGIUVL1rZowHXheI130_assertion description "[One area of gene therapy that has generated much debate and controversy is the use of vascular endothelial growth factor (VEGF) for therapeutic angiogenesis for palliative intent, and for the prevention of restenosis following percutaneous revascularization in coronary and peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448039.RA0caSYltOPQpHlLdzs9PrJH7AteYpGIUVL1rZowHXheI130_provenance.
- NP448036.RAb4k5zA8U2IpbCc8zfs6jSGFow7cduqwVnaxuqOCt9aQ130_assertion description "[One area of gene therapy that has generated much debate and controversy is the use of vascular endothelial growth factor (VEGF) for therapeutic angiogenesis for palliative intent, and for the prevention of restenosis following percutaneous revascularization in coronary and peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448036.RAb4k5zA8U2IpbCc8zfs6jSGFow7cduqwVnaxuqOCt9aQ130_provenance.
- NP448037.RAa3b8HRybneo4xdFqCWoqXpPpJtoCL9lsyF93iEJxJAI130_assertion description "[One area of gene therapy that has generated much debate and controversy is the use of vascular endothelial growth factor (VEGF) for therapeutic angiogenesis for palliative intent, and for the prevention of restenosis following percutaneous revascularization in coronary and peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448037.RAa3b8HRybneo4xdFqCWoqXpPpJtoCL9lsyF93iEJxJAI130_provenance.
- NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_assertion description "[One area of gene therapy that has generated much debate and controversy is the use of vascular endothelial growth factor (VEGF) for therapeutic angiogenesis for palliative intent, and for the prevention of restenosis following percutaneous revascularization in coronary and peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP771884.RAL75Ge5Gxb_3wS3JGYTJfx6qvteIdZdGfgres_Z1kv68130_provenance.